Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001913131 | SCV002175972 | uncertain significance | FADD-related immunodeficiency | 2021-06-19 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with FADD-related conditions. This variant is present in population databases (rs763073852, ExAC 0.002%). This sequence change replaces alanine with serine at codon 183 of the FADD protein (p.Ala183Ser). The alanine residue is weakly conserved and there is a moderate physicochemical difference between alanine and serine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. |